GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/VS System for diagnosing early gastric cancer
150

VS System for diagnosing early gastric cancer

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2025

VS Classification System for Diagnosing Early Gastric Cancer

The VS Classification System is a standardized diagnostic approach designed to detect early gastric cancer (EGC) using Narrow Band Imaging (NBI), a specialized endoscopic imaging technology. This system enhances the visualization of mucosal and vascular changes in the stomach lining, enabling precise and early detection of cancerous lesions.


Key Components of the VS Classification System

The VS system is based on the evaluation of two critical features:

  1. Vascular Pattern (V)

  2. Surface Pattern (S)

These features are assessed using magnifying endoscopy with NBI, which provides high-resolution images of the stomach's mucosal and submucosal layers.

1. Vascular Pattern (V)

  • Irregular Microvascular Architecture:
  • Distorted, tortuous, or dilated capillary structures.
  • Loss of normal vascular symmetry and organization.
  • Demarcation Line:
  • A clear boundary separating abnormal vascular patterns from surrounding normal mucosa.
  • Corkscrew Vessels:
  • Abnormal, twisted vessels often seen in early gastric cancer, indicative of neoplastic changes.

2. Surface Pattern (S)

  • Irregular Microsurface Structure:
  • Loss of normal pit patterns.
  • Presence of irregular, ridged, or nodular mucosal surface architecture.
  • White Zone Changes:
  • Areas of abnormal light reflection, suggesting mucosal damage or cancerous transformation.

Diagnostic Criteria

Early gastric cancer (EGC) is suspected when:

  1. Vascular Pattern:
  • Irregular microvascular architecture is observed.
  • A distinct demarcation line separates the lesion from normal mucosa.
  1. Surface Pattern:
  • Irregular microsurface structure is present.
  • White zone changes are visible.

When both vascular and surface irregularities are identified, the likelihood of EGC is significantly increased.


Clinical Applications

  1. Targeted Biopsy:
  • The VS system helps identify suspicious areas for biopsy, improving diagnostic accuracy and reducing unnecessary biopsies.
  1. Endoscopic Submucosal Dissection (ESD):
  • Lesions diagnosed using the VS system can be resected precisely via ESD, ensuring complete removal with clear margins.
  1. Surveillance:
  • High-risk patients (e.g., those with chronic atrophic gastritis or intestinal metaplasia) can be monitored using the VS system to detect EGC at an early stage.

Advantages of the VS Classification System

  1. High Sensitivity and Specificity:
  • Improves diagnostic accuracy compared to conventional white light endoscopy (WLE).
  • Sensitivity: ~88%; Specificity: ~75% (depending on study and operator expertise).
  1. Non-Invasive:
  • NBI is integrated into standard endoscopy systems, eliminating the need for dyes or additional equipment.
  1. Improved Diagnostic Yield:
  • Enhances the detection of subtle mucosal changes indicative of early gastric cancer.

Limitations

  1. Operator Dependence:
  • Requires expertise in magnifying NBI and familiarity with VS classification patterns.
  1. False Positives:
  • Inflammatory lesions or benign changes may mimic irregular vascular and surface patterns, leading to potential overdiagnosis.

Comparison: VS Classification vs White Light Endoscopy (WLE)

| Parameter | VS Classification (NBI) | White Light Endoscopy (WLE) |

|------------------------------|--------------------------------------|-----------------------------------------|

| Vascular Visualization | Enhanced with high contrast | Limited visualization |

| Surface Architecture | Detailed microsurface pattern | Poor resolution of surface patterns |

| Diagnostic Accuracy | Higher sensitivity and specificity | Lower sensitivity for early lesions |

| Targeted Biopsy | Precise biopsy sampling | Random biopsy sampling |


Clinical Evidence Supporting VS Classification

  1. Ezoe et al. (2011):
  • Demonstrated that magnifying NBI with the VS system was more accurate than WLE for diagnosing gastric mucosal cancer.
  • Sensitivity: 88%; Specificity: 75%.
  1. Zhang et al. (2016):
  • A meta-analysis showed that NBI combined with the VS classification significantly improved diagnostic efficacy for EGC.
  1. Dinis-Ribeiro et al. (2017):
  • Prospective studies confirmed that the VS system reduces unnecessary biopsies while maintaining high diagnostic accuracy.

Future Directions

  1. Artificial Intelligence (AI):
  • AI algorithms are being developed to automate the VS classification process, reducing operator dependency and enhancing diagnostic precision.
  1. Training Programs:
  • Structured training for endoscopists to improve proficiency in recognizing VS patterns and using NBI technology.
  1. Expansion to Other GI Cancers:
  • The VS classification system may be adapted for diagnosing other gastrointestinal cancers, such as esophageal or colorectal neoplasms.

Summary

The VS Classification System is a powerful tool for diagnosing early gastric cancer (EGC) using Narrow Band Imaging (NBI). By evaluating vascular patterns (irregular microvascular architecture, demarcation line) and surface patterns (irregular microsurface structure, white zone changes), the system provides high sensitivity and specificity for early cancer detection. It facilitates targeted biopsies, improves diagnostic accuracy, and supports precise therapeutic interventions like endoscopic submucosal dissection (ESD). Despite its operator dependency, the VS system represents a significant advancement in endoscopic imaging, offering the potential for earlier detection and better outcomes in gastric cancer management.

Related Q&A

151

Speed Boat Device - Novel Resection Technique

The Speedboat RS2 device, developed by Creo Medical Ltd, is an advanced bipolar electrosurgical tool designed for minimally invasive endoscopic procedures like Endoscopic Submucosal Dissection (ESD) and Peroral...

152

EndoFLIP

EndoFLIP (Endolumenal Functional Lumen Imaging Probe): A Comprehensive Overview EndoFLIP is an advanced diagnostic tool designed to measure esophageal distensibility and sphincter compliance in real time. It is...

153

Efficacy and Safety of ARMS versus Stretta in GERD

The comparison of Anti-Reflux Mucosectomy (ARMS) and Radiofrequency Ablation (Stretta) for the treatment of Gastroesophageal Reflux Disease (GERD) highlights differences in efficacy and safety profiles. Here's a detailed...

154

Endoscopic Sleeve Gastroplasty on Obesity-Related Comorbidities

Endoscopic Sleeve Gastroplasty (ESG) has shown significant promise in managing obesity-related comorbidities, as evidenced by a prospective 5-year study. Here are the key findings related to its impact:...

155

Post ERCP-Induced Perforation

Endoscopic retrograde cholangiopancreatography (ERCP)-induced perforation is a rare but serious complication that requires prompt diagnosis and appropriate management to minimize morbidity and mortality. Management strategies are guided by...

156

pHoenix Score for GERD Using 24-Hour pH Monitoring

The pHoenix Score (pHx-S) is a novel diagnostic metric developed to enhance the accuracy of diagnosing gastroesophageal reflux disease (GERD) using 24-hour pH monitoring. It addresses limitations of...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer